If OTAT has asked for more information would that not necessitate an announcement from MSB to the market?
It makes sense what you are saying and if you are on the money
(Usually you are close to the bullseye)
won’t that rub off onto the other indications like CHF & LBP even though it is a different product?
And by default derail all forward momentum in everything MSB is trying to get past the FDA?
Ann: Update on Novartis Agreement, page-131
-
- There are more pages in this discussion • 720 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |